Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes

Alessandra Ferraro, Carlo Socci, Angela Stabilini, Andrea Valle, Paolo Monti, Lorenzo Piemonti, Rita Nano, Sven Olek, Paola Maffi, Marina Scavini, Antonio Secchi, Carlo Staudacher, Ezio Bonifacio, Manuela Battaglia

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

OBJECTIVE - Autoimmune diseases, including type 1 diabetes, are thought to have a Th17-cell bias and/or a T-regulatory cell (Treg) defect. Understanding whether this is a hallmark of patients with type 1 diabetes is a crucial question that is still unsolved, largely due to the difficulties of accessing tissues targeted by the disease. RESEARCH DESIGN AND METHODS - We phenotypically and functionally characterized Th17 cells and Tregs residing in the pancreatic-draining lymph nodes (PLNs) of 19 patients with type 1 diabetes and 63 nondiabetic donors and those circulating in the peripheral blood of 14 type 1 diabetic patients and 11 healthy subjects. RESULTS - We found upregulation of Th17 immunity and functional defects in CD4 +CD25 bright Tregs in the PLNs of type 1 diabetic subjects but not in their peripheral blood. In addition, the proinsulin-specific Treg-mediated control was altered in the PLNs of diabetic patients. The dysfunctional Tregs isolated from diabetic subjects did not contain contaminant effector T cells and were all epigenetically imprinted to be suppressive, as defined by analysis of the Treg-specific demethylated region within the forkhead box P3 (FOXP3) locus. CONCLUSIONS - These data provide evidence for an unbalanced immune status in the PLNs of type 1 diabetic subjects, and treatments restoring the immune homeostasis in the target organ of these patients represent a potential therapeutic strategy.

Original languageEnglish
Pages (from-to)2903-2913
Number of pages11
JournalDiabetes
Volume60
Issue number11
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Th17 Cells
Regulatory T-Lymphocytes
Type 1 Diabetes Mellitus
Lymph Nodes
Proinsulin
Autoimmune Diseases
Immunity
Healthy Volunteers
Homeostasis
Research Design
Up-Regulation
Tissue Donors
T-Lymphocytes
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. / Ferraro, Alessandra; Socci, Carlo; Stabilini, Angela; Valle, Andrea; Monti, Paolo; Piemonti, Lorenzo; Nano, Rita; Olek, Sven; Maffi, Paola; Scavini, Marina; Secchi, Antonio; Staudacher, Carlo; Bonifacio, Ezio; Battaglia, Manuela.

In: Diabetes, Vol. 60, No. 11, 11.2011, p. 2903-2913.

Research output: Contribution to journalArticle

Ferraro, Alessandra ; Socci, Carlo ; Stabilini, Angela ; Valle, Andrea ; Monti, Paolo ; Piemonti, Lorenzo ; Nano, Rita ; Olek, Sven ; Maffi, Paola ; Scavini, Marina ; Secchi, Antonio ; Staudacher, Carlo ; Bonifacio, Ezio ; Battaglia, Manuela. / Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. In: Diabetes. 2011 ; Vol. 60, No. 11. pp. 2903-2913.
@article{18a131f6d3144fefba6e9787dc2125d4,
title = "Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes",
abstract = "OBJECTIVE - Autoimmune diseases, including type 1 diabetes, are thought to have a Th17-cell bias and/or a T-regulatory cell (Treg) defect. Understanding whether this is a hallmark of patients with type 1 diabetes is a crucial question that is still unsolved, largely due to the difficulties of accessing tissues targeted by the disease. RESEARCH DESIGN AND METHODS - We phenotypically and functionally characterized Th17 cells and Tregs residing in the pancreatic-draining lymph nodes (PLNs) of 19 patients with type 1 diabetes and 63 nondiabetic donors and those circulating in the peripheral blood of 14 type 1 diabetic patients and 11 healthy subjects. RESULTS - We found upregulation of Th17 immunity and functional defects in CD4 +CD25 bright Tregs in the PLNs of type 1 diabetic subjects but not in their peripheral blood. In addition, the proinsulin-specific Treg-mediated control was altered in the PLNs of diabetic patients. The dysfunctional Tregs isolated from diabetic subjects did not contain contaminant effector T cells and were all epigenetically imprinted to be suppressive, as defined by analysis of the Treg-specific demethylated region within the forkhead box P3 (FOXP3) locus. CONCLUSIONS - These data provide evidence for an unbalanced immune status in the PLNs of type 1 diabetic subjects, and treatments restoring the immune homeostasis in the target organ of these patients represent a potential therapeutic strategy.",
author = "Alessandra Ferraro and Carlo Socci and Angela Stabilini and Andrea Valle and Paolo Monti and Lorenzo Piemonti and Rita Nano and Sven Olek and Paola Maffi and Marina Scavini and Antonio Secchi and Carlo Staudacher and Ezio Bonifacio and Manuela Battaglia",
year = "2011",
month = "11",
doi = "10.2337/db11-0090",
language = "English",
volume = "60",
pages = "2903--2913",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "11",

}

TY - JOUR

T1 - Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes

AU - Ferraro, Alessandra

AU - Socci, Carlo

AU - Stabilini, Angela

AU - Valle, Andrea

AU - Monti, Paolo

AU - Piemonti, Lorenzo

AU - Nano, Rita

AU - Olek, Sven

AU - Maffi, Paola

AU - Scavini, Marina

AU - Secchi, Antonio

AU - Staudacher, Carlo

AU - Bonifacio, Ezio

AU - Battaglia, Manuela

PY - 2011/11

Y1 - 2011/11

N2 - OBJECTIVE - Autoimmune diseases, including type 1 diabetes, are thought to have a Th17-cell bias and/or a T-regulatory cell (Treg) defect. Understanding whether this is a hallmark of patients with type 1 diabetes is a crucial question that is still unsolved, largely due to the difficulties of accessing tissues targeted by the disease. RESEARCH DESIGN AND METHODS - We phenotypically and functionally characterized Th17 cells and Tregs residing in the pancreatic-draining lymph nodes (PLNs) of 19 patients with type 1 diabetes and 63 nondiabetic donors and those circulating in the peripheral blood of 14 type 1 diabetic patients and 11 healthy subjects. RESULTS - We found upregulation of Th17 immunity and functional defects in CD4 +CD25 bright Tregs in the PLNs of type 1 diabetic subjects but not in their peripheral blood. In addition, the proinsulin-specific Treg-mediated control was altered in the PLNs of diabetic patients. The dysfunctional Tregs isolated from diabetic subjects did not contain contaminant effector T cells and were all epigenetically imprinted to be suppressive, as defined by analysis of the Treg-specific demethylated region within the forkhead box P3 (FOXP3) locus. CONCLUSIONS - These data provide evidence for an unbalanced immune status in the PLNs of type 1 diabetic subjects, and treatments restoring the immune homeostasis in the target organ of these patients represent a potential therapeutic strategy.

AB - OBJECTIVE - Autoimmune diseases, including type 1 diabetes, are thought to have a Th17-cell bias and/or a T-regulatory cell (Treg) defect. Understanding whether this is a hallmark of patients with type 1 diabetes is a crucial question that is still unsolved, largely due to the difficulties of accessing tissues targeted by the disease. RESEARCH DESIGN AND METHODS - We phenotypically and functionally characterized Th17 cells and Tregs residing in the pancreatic-draining lymph nodes (PLNs) of 19 patients with type 1 diabetes and 63 nondiabetic donors and those circulating in the peripheral blood of 14 type 1 diabetic patients and 11 healthy subjects. RESULTS - We found upregulation of Th17 immunity and functional defects in CD4 +CD25 bright Tregs in the PLNs of type 1 diabetic subjects but not in their peripheral blood. In addition, the proinsulin-specific Treg-mediated control was altered in the PLNs of diabetic patients. The dysfunctional Tregs isolated from diabetic subjects did not contain contaminant effector T cells and were all epigenetically imprinted to be suppressive, as defined by analysis of the Treg-specific demethylated region within the forkhead box P3 (FOXP3) locus. CONCLUSIONS - These data provide evidence for an unbalanced immune status in the PLNs of type 1 diabetic subjects, and treatments restoring the immune homeostasis in the target organ of these patients represent a potential therapeutic strategy.

UR - http://www.scopus.com/inward/record.url?scp=80755148666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80755148666&partnerID=8YFLogxK

U2 - 10.2337/db11-0090

DO - 10.2337/db11-0090

M3 - Article

C2 - 21896932

AN - SCOPUS:80755148666

VL - 60

SP - 2903

EP - 2913

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 11

ER -